CDAN

Howard Chertkow is a cognitive neurologist, founder (with Howard Bergman) and director of the JGH/ McGill Memory Clinic. Dr. Chertkow is a member of the Jewish General Hospital’s Dept. of Clinical Neuroscience and Division of Geriatric Medicine.

Dr. Chertkow’s major areas of research interest include 1) Early diagnosis of Alzheimer’s Disease and prediction of deterioration in individuals with Mild Cognitive Impairment. 2) the structure, organization, and function of the Semantic Memory component of long term memory, and its deterioration in dementia , 3)  localization of language and memory functions in the brain using functional imaging. He has been continuously funded by the CIHR (Canadian Institutes for Health Research) and its forerunner, the MRC, for the past 18 years, and currently holds CIHR grants to explore the natural history of Mild Cognitive Impairment and the neural substrate of semantic memory. His CV lists 258 publications, including  110 peer-reviewed articles and chapters. Dr. Chertkow’s salary support has included a prestigious “Chercheur national” award from the FRSQ.

Dr. Chertkow is past president of the Consortium of Canadian Centres for Clinical Cognitive Research (C5R). He was previously coordinator of the cognition axis of the provincial FRSQ network on Aging. He currently sits on the Research Advisory Board of the Alzheimer Society of Canada, and a Quebec government board to draw up a provincial strategy for dementia management. In 2006 he chaired the Third Canadian Consensus Conference on the Diagnosis and Treatment of Dementia, which brought together many of the country’s experts to formulate new guidelines for physicians. Results have been published nationally and internationally and will form the basis of physician training and government policy in Canada regarding dementia in the coming years.  These results are being disseminated with the support of “knowledge transfer” grants from the CIHR to Dr. Chertkow. In 2008 Dr. Chertkow received the national Irma Parhad Award from C5R for contributions to excellence in Alzheimer’s Disease research.